Inhibitors of Kallikrein in Human Plasma

AUTOR(ES)

McConnell, David J.

RESUMO

Human plasma was fractionated by ammonium sulfate precipitation, DEAE-cellulose chromatography, and Sephadex G-200 gel filtration to determine which method would give the greatest number of clearly separable kallikrein inhibitory peaks. With G-200 gel filtration three peaks could be separated which were demonstrated to contain α2-macroglobulin, C1̄ inactivator, and α1-antitrypsin. No other kallikrein inhibitors could be identified. The fractions containing C1̄ inactivator and α2-macroglobulin appeared to be more effective against kallikrein than that containing α1-antitrypsin. A patient with hereditary angioneurotic edema was shown to have an abnormal C1̄ inactivator protein capable of interfering with kallikrein's biologic, but not its esterolytic activity. Heat-treated human plasma, a commonly used source of kininogen for experiments with kallikrein, was shown to have kallikrein inhibitory activity.

Documentos Relacionados

• Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma
• Inactivation of kallikrein in human plasma.
• Glycosaminoglycans affect the interaction of human plasma kallikrein with plasminogen, factor XII and inhibitors
• Purified human plasma kallikrein aggregates human blood neutrophils.
• Studies on the prekallikrein (kallikreinogen)—kallikrein enzyme system of human plasma: II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein